Business Wire

LifeArc and GVK BIO Celebrate a Decade of Partnership, Transforming Research into Life-Saving Medicines

Share

GVK BIO, a leading global Contract Research and Development Organisation (CRDO), and LifeArc, one of UK’s top medical research charities, are pleased to announce the 10th anniversary of a successful partnership. The collaboration between LifeArc and GVK BIO brings together two organizations with a singular vision: advancing novel research ideas into potential medicines that can make a significant difference to patients.

LifeArc’s novel approach involves levering partnerships with academia and leading service organizations to advance discoveries into promising medicines. Over the past decade, LifeArc scientific teams have focused their efforts on modulating novel targets with therapeutic potential in diseases where there is patient need, with the GVK BIO team assisting in synthesizing complex molecules rapidly and cost effectively to drive iterative improvement in efficacy and safety.

Promising novel chemical entities discovered from this partnership have been either advanced by LifeArc into clinical development, or have been licensed out to leading global pharmaceutical companies, including a recently announced deal in neuroscience. As the partnership evolved from a tactical relationship into a preferred partnership, the GVK BIO team has augmented LifeArc’s internal biology efforts, by supporting biochemical assays, carrying out drug metabolism and pharmacokinetics profiling studies, and soon, will be developing cell-based assays and running protein expression and purification studies.

“It has been our privilege to have collaborated with LifeArc and its world class team of scientists that have delivered medicines such as Keytruda®, Tysabri®, and Entyvio® among others,” said Manni Kantipudi, Director & Chief Executive Officer, GVK BIO. “The longevity of this partnership, and the transformative results of the collaboration, serve as a testament to the capabilities of the GVK BIO team and its commitment to work with customers to make a difference in human life. We look forward to continuing this successful relationship with LifeArc in the coming years.”

Commenting on the partnership, Melanie Lee, Chief Executive Officer, LifeArc, said, “At LifeArc, we’re committed to translating scientific innovation to benefit patients. Our partnership with GVK BIO is a strong example of how shared goals and collaboration can create real value.”

About GVK BIO

GVK BIO, a leading Contract Research & Development Organization servicing the global Biopharma industry; is headquartered in Hyderabad, India with operations in five sites including California, USA. Established in 2001, GVK BIO has over 18 years of experience across the Research and Development value chain with a focus on speed and quality while ensuring safety and compliance. GVK BIO’s team of over 2100 highly qualified scientists, backed by a no-conflict business model, well-defined and scalable processes, modern facilities, and a strong customer-centric partnering approach, focus on bringing its customers’ products to market. www.gvkbio.com

About LifeArc

LifeArc is a self-funded medical research charity. Our mission is to advance translation of early science into health care treatments or diagnostics that can be taken through to full development and made available to patients. We’ve been doing this for more than 25 years and our work has resulted in four licensed medicines and a diagnostic for antibiotic resistance. Our success allows us to explore new approaches to stimulate and fund translation. We have our own drug discovery and diagnostics facilities, supported by experts in technology transfer and intellectual property who also provide services to external clients. Our model is built on collaboration, and we partner with a broad range of groups including medical research charities, research organisations, industry and scientists. www.lifearc.org ; Twitter @lifearc1

Contact information

Dorothy Paul
Dorothy.paul@gvkbio.com
+91 9908130236

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Mundipharma Announces the Licence Extension Submission for Invokana® (canagliflozin) and Vokanamet® (canagliflozin and metformin) to the European Medicines Agency22.8.2019 02:01:00 EESTPress release

STRICTLY FOR EUROPEAN MEDICAL AND PHARMACEUTICAL TRADE MEDIA ONLY As the European distributor of Invokana® (canagliflozin) and Vokanamet® (canagliflozin and metformin), Mundipharma welcomes the news that the European Medicines Agency (EMA) has accepted the licence extension submission for these two medicines to treat stage 2 or stage 3 chronic kidney disease (CKD) and albuminuria as an adjunct to standard of care in adults with type 2 diabetes mellitus (T2DM). The submission is based on the results from the landmark Phase III CREDENCE study1 which evaluated the efficacy and safety of canagliflozin versus placebo in this high-risk patient population when used in addition to standard of care. “Chronic kidney disease is a serious complication of type 2 diabetes, which can increase patients’ risk of developing end-stage renal disease and may reduce their life expectancy by several years.” said Dr Vinicius Gomes de Lima, European Medical Affairs Lead, Mundipharma. “If approved, this licence

Triton Digital Releases Webcast Metrics Rankings for the Top Digital Audio Properties for April 201921.8.2019 23:00:00 EESTPress release

Triton Digital®, the global technology and services leader to the digital audio and podcast industry, released today its monthly Webcast Metrics® rankers for April 2019. The global rankers, in addition to the U.S., LATAM, and EMEA regional rankers provide insight into the top-performing streaming audio stations and networks around the world for the month of April. The full results of the Global & Regional Rankers for April 2019 can be found here: https://www.tritondigital.com/resources/monthly-rankers/rankers-archive The Webcast Metrics streaming measurement service is the industry standard for online audio consumption data. It provides credible, validated data that enables audio publishers around the world to analyze the consumption of their audio content by daypart, device type, geography, distribution platform, and more. About Triton Digital Triton Digital® is the global technology and services leader to the digital audio and podcast industry. Operating in more than 40 countries, Tr

Celsius Partners With Tether to Bring USDT its Highest Interest-earning Wallet at 10.53% APR21.8.2019 18:15:00 EESTPress release

Celsius Network (https://celsius.network/), the industry-leading cryptocurrency platform, announces today its partnership with Tether, a stablecoin which pegs its value to the US dollar. The Celsius app now supports the USDT ERC20 stablecoin allowing USDT holders to earn rewards and request loans on a far less volatile asset than other cryptocurrencies. Celsius users can now request a loan issued in USDT, in addition to the existing stablecoins and fiat loan options available through Celsius, at rates as low as 4.95% APR. The company currently offers interest income of 8.1% APR on USDT deposits and 10.53% when paid in CEL tokens. At the same time, using stablecoins reduces capital costs, allowing Celsius to offer loans at a lower rate. Celsius has achieved notable milestones in the past year to drive the decentralization of traditional financial structures: Over $2.2 billion worth of coin loans originated since July 2018 Over $350 million AUM in customer deposits and collateral from lo

The World's First 5nm Generation AI Chip is Taped Out - TeraPixel Technologies, Inc.21.8.2019 17:00:00 EESTPress release

TeraPixel Technologies Inc. (Representative: Naoki Kawahara) taped out “Extrixa Processor” as the first deep-learning AI product on March 8, 2019 as the world's first chip that uses TSMC 5nm. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190821005023/en/ Picture of Mechanical Sample for 5nm Deep Learning AI Processor (Photo: Business Wire) Wafer equipped with ASIC implemented in the world's most advanced process rolls out on August 25 and is scheduled to be available in early September after assembly testing. This 5nm process will be used to check the core performance and power consumption since SRAM cells were not yet prepared at the time of tape-out in March. In the first quarter of 2020, we will tape out the second version with the same functions as the product version with SRAM and other functional blocks. TeraPixel has R & D technology for massively parallel processors with many cores, aiming for the world's highest le

Cummins President and COO Rich Freeland Retiring21.8.2019 16:00:00 EESTPress release

Cummins Inc. (NYSE: CMI) announced today that President and COO, Rich Freeland will retire after forty years of service with Cummins. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190821005396/en/ Rich Freeland (Photo: Business Wire) As part of Cummins’ successions plans, the following leadership appointments are also taking place, all of which are effective October 15. Distribution President Tony Satterthwaite will succeed Freeland as President and COO. Components President Tracy Embree will succeed Satterthwaite as Distribution Business President. Chief Technical Officer Jennifer Rumsey will succeed Embree as Components Business President. Jim Fier will succeed Rumsey as Chief Technical Officer. “I want to personally thank Rich for his many contributions to Cummins and his friendship and support over the 25 years I have known and worked with him,” said Tom Linebarger, Chairman and CEO, Cummins Inc. “He is one of the most

Open Web Automation (OWA): How logi.cals Reinvents the World of PLC Programming and Engineering21.8.2019 15:32:00 EESTPress release

"Never Touch a Running System" is still a central unwritten law in machine and plant engineering. Once an application operates, function and programming are changed as little as possible. This is however no longer up-to-date, as companies with this approach in the automation and engineering process are increasingly lagging behind the requirements for flexibility, time-to-market and quality. Dynamizing the adaptation of the programming of a machine or plant to new tasks requires innovative engineering tools and environments. Open Web Automation (OWA) is logi.cals' answer as a flexible and dynamically evolving automation system that guides the user: from the plant model to configuration, engineering, automated testing, simulation, visualization and beyond. Supporting numerous open standards such as OPC UA, Automation ML or the IEC61131 languages, OWA is the platform for open automation applications. OWA is a modular cloud architecture, which with its browser-based core components, numero

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom